Bone health in epilepsy

Hahn, 1972, Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults, N Engl J Med, 287, 900, 10.1056/NEJM197211022871803 Richens, 1970, Disturbance of calcium metabolism by anticonvulsant drugs, Br Med J, 4, 73, 10.1136/bmj.4.5727.73 Tolman, 1975, Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children, Pediatrics, 56, 45, 10.1542/peds.56.1.45 Hahn, 1975, Haddad JG: Serum 25- hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy, N Engl J Med, 292, 550, 10.1056/NEJM197503132921102 Christiansen, 1973, Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial, BMJ, 4, 695, 10.1136/bmj.4.5894.695 Mosekilde, 1977, The interrelationships between serum 25-hydroxycholcalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia, Acta Endocrinol, 84, 559, 10.1530/acta.0.0840559 Sotaniemi, 1972, Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy, Ann Intern Med, 77, 389, 10.7326/0003-4819-77-3-389 Holick, 2001, Introduction to bone and mineral metabolism, 2192 Garn, 1970 Bouillon, 1975, The effect of anticonvulsant therapy on serum levels of 25-hydroxyvitamin D, calcium, and parathyroid hormone, J Clin Endocrinol Metab, 41, 1130, 10.1210/jcem-41-6-1130 Berry, 1983, Effect of antiepileptic drug therapy and exposure to sunlight on vitamin D status in institutionalized patients, 185 Gough, 1986, A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in outpatients with epilepsy, Q J Med, 230, 569 Hoikka, 1980, Biochemical evidence for osteomalacia with carbamazepine therapy, Acta Neurol Scand, 62, 282 Bogliun, 1986, Anticonvulsant drugs and bone metabolism, Acta Neurol Scand, 74, 284, 10.1111/j.1600-0404.1986.tb03515.x Andress, 2002, Antiepileptic drug-induced bone loss in young male patients who have seizures, Arch Neurol, 59, 781, 10.1001/archneur.59.5.781 Skillen, 1976, Serum gamma glutamyl transferase and alkaline phosphatase activities in epileptics receiving anticonvulsant therapy, Clin Chim Acta, 72, 245, 10.1016/0009-8981(76)90080-2 Stamp, 1972, Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs, Br Med J, 4, 9, 10.1136/bmj.4.5831.9 Tjellesen, 1982, Serum vitamin D metabolites in epileptic patients treated with 2 different anticonvulsants, Acta Neurol Scand, 66, 335, 10.1111/j.1600-0404.1982.tb06853.x Sato, 2001, Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy, Neurology, 57, 445, 10.1212/WNL.57.3.445 Weinstein, 1984, Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment, J Clin Endocrinol Metab, 58, 1003, 10.1210/jcem-58-6-1003 Valimaki, 1994, Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on anti-epileptic drugs, J Bone Miner Res, 9, 631, 10.1002/jbmr.5650090507 O'Hare, 1980, Biochemical evidence for osteomalacia with carbamazepine therapy, Acta Neurol Scand, 62, 282, 10.1111/j.1600-0404.1980.tb03037.x Okesina, 1991, Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy, J Clin Pathol, 44, 480, 10.1136/jcp.44.6.480 Takeshita, 1989, Increased circulating levels of gamma-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy, Calcif Tissue Int, 44, 80, 10.1007/BF02556465 Verrotti, 2000, Increased bone turnover in epileptic patients treated with carbamazepine, Ann Neurol, 47, 385, 10.1002/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W Verrotti, 2002, Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine, Epilepsia, 43, 1488, 10.1046/j.1528-1157.2002.13002.x 2017, Recommended dietary allowances for macronutrients, 89 2010 Menon, 2010, Prevalence of low dietary calcium intake in patients with epilepsy: a study from South India, Neurol India, 58, 209, 10.4103/0028-3886.63793 Koppel, 2005, An analysis of lifetime fractures in women with epilepsy, Acta Neurol Scand, 111, 225, 10.1111/j.1600-0404.2005.00399.x Sheth, 2006, Pathological fractures in epilepsy, Epilepsy Behav, 9, 601, 10.1016/j.yebeh.2006.08.003 Vestergaard, 1999, Fracture risk is increased in epilepsy, Acta Neurol Scand, 99, 269, 10.1111/j.1600-0404.1999.tb00675.x Souverein, 2005, Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database, Epilepsia, 46, 304, 10.1111/j.0013-9580.2005.23804.x Persson, 2002, Risk of extremity fractures in adult outpatients with epilepsy, Epilepsia, 43, 768, 10.1046/j.1528-1157.2002.15801.x Appleton, 2002, Seizure-related injuries in children with newly diagnosed and untreated epilepsy, Epilepsia, 43, 764, 10.1046/j.1528-1157.2002.41101.x Petty, 2005, Effect of antiepileptic medication on bone mineral measures, Neurology, 65, 1358, 10.1212/01.wnl.0000180910.72487.18 Farhat, 2002, Effect of antiepileptic drugs on bone density in ambulatory patients, Neurology, 58, 1348, 10.1212/WNL.58.9.1348 Pack, 2012, Falls and fractures in patients with epilepsy Is there an increased risk? If so, why?, Neurology, 79, 119, 10.1212/WNL.0b013e31825f06f9 Ensrud, 2004, Antiepileptic drug use increases rates of bone loss in older women: a prospective study, Neurology, 62, 2051, 10.1212/01.WNL.0000125185.74276.D2 Nicholas, 2013, Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database, Seizure, 22, 37, 10.1016/j.seizure.2012.10.002 Shen, 2014, Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis, Bone, 64, 246, 10.1016/j.bone.2014.04.018 Fitzpatrick, 2004, Pathophysiology of bone loss in patients receiving anticonvulsant therapy, Epilepsy Behav, 5, S3, 10.1016/j.yebeh.2003.11.026 Hamersvelt, 1998, Brains and bones, Nephrol Dial Transplant, 13, 801, 10.1093/ndt/13.3.801 Sheth, 1995, Effect of carbamazapine and valproate on bone mineral density, J Pediatr, 127, 256, 10.1016/S0022-3476(95)70304-7 Chung, 1994, Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children, Brain Dev, 16, 382, 10.1016/0387-7604(94)90125-2 Koch, 1972, Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat, Epilepsia, 13, 829, 10.1111/j.1528-1157.1972.tb05167.x Zhou, 2006, Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia, J Clin Invest, 116, 1703, 10.1172/JCI27793 Tomita, 1991, The effect of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase system, J Steroid Biochem Mol Biol, 39, 479, 10.1016/0960-0760(91)90241-V Theodoropoulos, 2001, 1, 25-dihydroxy D3 down regulates the rat intestinal vitamin D3-25 hydroxylase CYP27A, Am J Physiol, 281, E315 Holick, 2005, Stay tuned to PXR: an orphan actor that may not be D-structive only to bone, J Clin Invest, 115, 32, 10.1172/JCI200523995 Takahashi, 2000, Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria, Jpn J Pharmacol, 82, 82, 10.1254/jjp.82.82 Vernillo, 1990, Phenytoin affects osteoblastic secretion from osteoblastic rat osteosarcoma 17/2.8 cells in culture, Bone, 11, 309, 10.1016/8756-3282(90)90085-D Kruse, 1987, Monomeric serum calcitonin and bone turnover during anticonvulsant treatment and in congenital hypothyroidism, J Pediatr, 111, 57, 10.1016/S0022-3476(87)80342-6 Pack, 2008, Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy, Neurology, 70, 1586, 10.1212/01.wnl.0000310981.44676.de Davie, 1983, Low plasma 25-hydroxyvitamin D and serum calcium in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D, Q J Med, 205, 79 Kafali, 1999, Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years, Clin Pediatr, 38, 93, 10.1177/000992289903800205 Sheth, 1995, Effect of carbamazapine and valproate on bone mineral density, J Pediatr, 127, 256, 10.1016/S0022-3476(95)70304-7 Stephen, 1999, Bone density and antiepileptic drugs: a case controlled study, Seizure, 8, 339, 10.1053/seiz.1999.0301 Guo, 2001, Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy, Epilepsia, 42, 1141, 10.1046/j.1528-1157.2001.416800.x Sheth, 2007, Bone mineral density with lamotrigine monotherapy for epilepsy, Pediatr Neurol, 37, 250, 10.1016/j.pediatrneurol.2007.05.018 Ensrud, 2008, Osteoporotic Fractures in Men (MrOS) Study Research Group: antiepileptic drug use and rates of hip bone loss in older men: a prospective study, Neurology, 71, 723, 10.1212/01.wnl.0000324919.86696.a9 Menon, 2010, The effect of anti-epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism—A longitudinal study, Seizure, 19, 153, 10.1016/j.seizure.2010.01.006 Hakami, 2016, Monotherapy with levetiracetam versus older AEDs: a randomized comparative trial of effects on bone health, Calcif Tissue Int, 98, 556, 10.1007/s00223-016-0109-7 Artemiadis, 2016, Bougea A, etal. Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy, Epilepsy Behav, 55, 84, 10.1016/j.yebeh.2015.12.025 Vestergaard, 2015, Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy, Paediatr Drugs, 17, 141, 10.1007/s40272-014-0115-z Sheth, 2008, Gender differences in bone mineral density in epilepsy, Epilepsia, 49, 125, 10.1111/j.1528-1167.2007.01253.x Lin, 2016, Potential effects of valproate and oxcarbazepine on growth velocity and bonemetabolism in epileptic children- a medical center experience, BMC Pediatr, 3, 61, 10.1186/s12887-016-0597-7 Serin, 2015, The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine, Epilepsy Behav, 51, 221, 10.1016/j.yebeh.2015.06.025 Fong, 2016, Vitamin D deficiency and its risk factors in Malaysian children with epilepsy, Epilepsia Mikati, 2006, Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone, Neurology, 67, 2005, 10.1212/01.wnl.0000247107.54562.0e Harden, 1999, The effect of menopause and perimenopause on the course of epilepsy, Epilepsia, 40, 1402, 10.1111/j.1528-1157.1999.tb02012.x Dilip, 2011, Epilepsy, anti-epileptic drugs and bone health in children, J Pediatr Neurosci, 6, 93 Vinayan, 2006, Epilepsy, antiepileptic drugs and bone health, Ann Indian Acad Neurol, 9, 90, 10.4103/0972-2327.25980